SE8701457L - IMMUNOSTIMULATING TRIPEPTIDES - Google Patents

IMMUNOSTIMULATING TRIPEPTIDES

Info

Publication number
SE8701457L
SE8701457L SE8701457A SE8701457A SE8701457L SE 8701457 L SE8701457 L SE 8701457L SE 8701457 A SE8701457 A SE 8701457A SE 8701457 A SE8701457 A SE 8701457A SE 8701457 L SE8701457 L SE 8701457L
Authority
SE
Sweden
Prior art keywords
arg
tripeptide
ala
salts
immunostimulating
Prior art date
Application number
SE8701457A
Other languages
Unknown language ( )
Swedish (sv)
Other versions
SE8701457D0 (en
Inventor
B Brunetti
M Prado
Original Assignee
Ellem Ind Farmaceutica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ellem Ind Farmaceutica filed Critical Ellem Ind Farmaceutica
Publication of SE8701457D0 publication Critical patent/SE8701457D0/en
Publication of SE8701457L publication Critical patent/SE8701457L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Abstract

The present invention relates to the use of a tripeptide consisting of L-Ala (alanine) and L-Arg (arginine), or its salts thereof and having the following structure: Arg-Ala-Arg for the preparation of a pharmaceutical composition useful as an immunostimulant. The above tripeptide indeed has a strong immunostimulating activity both on maturation of immature T cells and on T cell function. Compositions comprising this tripeptide or its salts thereof in admixture with a pharmaceutically acceptable carrier are also disclosed.
SE8701457A 1986-04-09 1987-04-07 IMMUNOSTIMULATING TRIPEPTIDES SE8701457L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20027/86A IT1188646B (en) 1986-04-09 1986-04-09 TRIPEPTIDE WITH IMMUNOSTIMULANT ACTIVITY

Publications (2)

Publication Number Publication Date
SE8701457D0 SE8701457D0 (en) 1987-04-07
SE8701457L true SE8701457L (en) 1987-10-10

Family

ID=11163225

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8701457A SE8701457L (en) 1986-04-09 1987-04-07 IMMUNOSTIMULATING TRIPEPTIDES

Country Status (17)

Country Link
JP (1) JPH0645637B2 (en)
KR (1) KR870010080A (en)
AR (1) AR242799A1 (en)
AT (1) ATA88387A (en)
AU (1) AU597048B2 (en)
BE (1) BE1000263A4 (en)
CA (1) CA1322715C (en)
CH (1) CH676467A5 (en)
DE (1) DE3712050A1 (en)
ES (1) ES2003043A6 (en)
FR (1) FR2597107B1 (en)
GB (1) GB2189491B (en)
GR (1) GR870568B (en)
IE (1) IE59806B1 (en)
IT (1) IT1188646B (en)
NL (1) NL8700827A (en)
SE (1) SE8701457L (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2058553C1 (en) * 1994-03-18 1996-04-20 Иван Николаевич Головистиков Method of estimation of human immune status suppressive link
RU2056852C1 (en) * 1994-03-18 1996-03-27 Иван Николаевич Головистиков Agent for treatment of autoimmune diseases with suppressor immunodeficiency and a method of autoimmune diseases treatment
GB0130285D0 (en) * 2001-12-19 2002-02-06 Astrazeneca Ab Chemical process
GB0130286D0 (en) * 2001-12-19 2002-02-06 Astrazeneca Ab Chemical process

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3778426A (en) * 1970-12-16 1973-12-11 Research Corp Therapeutically useful polypeptides
US4215112A (en) * 1979-03-14 1980-07-29 Ortho Pharmaceutical Corporation Tripeptides and methods

Also Published As

Publication number Publication date
NL8700827A (en) 1987-11-02
IT1188646B (en) 1988-01-20
GB2189491A (en) 1987-10-28
DE3712050C2 (en) 1992-02-13
KR870010080A (en) 1987-11-30
CA1322715C (en) 1993-10-05
GR870568B (en) 1987-08-12
JPH0645637B2 (en) 1994-06-15
IT8620027A1 (en) 1987-10-09
FR2597107A1 (en) 1987-10-16
GB8708492D0 (en) 1987-05-13
IE59806B1 (en) 1994-04-06
DE3712050A1 (en) 1987-10-15
AU597048B2 (en) 1990-05-24
IT8620027A0 (en) 1986-04-09
JPS62267296A (en) 1987-11-19
FR2597107B1 (en) 1991-02-22
ATA88387A (en) 1996-05-15
GB2189491B (en) 1990-02-21
ES2003043A6 (en) 1988-10-01
SE8701457D0 (en) 1987-04-07
AU7118287A (en) 1987-10-15
CH676467A5 (en) 1991-01-31
BE1000263A4 (en) 1988-09-27
AR242799A1 (en) 1993-05-31
IE870881L (en) 1987-10-09

Similar Documents

Publication Publication Date Title
ES8801930A1 (en) N,N-dialkylguanidino dipeptides.
DK0720482T3 (en) Prosaposin and cytokine-derived peptides as therapeutic agents
NO813138L (en) PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICALLY ACTIVE AMIDINE DERIVATIVES.
MX9702666A (en) New peptides with immunomodulatory effects.
MY104909A (en) Peptide compounds.
AU1031697A (en) Novel geranylgeranyl-derivatives, process for the preparation thereof and related pharmaceutical compositions
SE8701457L (en) IMMUNOSTIMULATING TRIPEPTIDES
DK149091C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF PEPTIDS CONTAINING 2-7 AMINO ACID RESIDUES, DESAMINODIPEPTIDES OR AMIDES THEREOF WITH UBIQUITIN SIMILAR ACTIVITY OR PHARMACEUTICAL ACCEPTABLE ACID ADDITIONAL SALTS
GB1386939A (en) Alkyl esters of alpha-aspartyl alpha-alkyl aliphatic amino acid dipeptides
GB1526367A (en) Polypeptide
MY110004A (en) Biologically active ureido derivatives useful as antimetastatic agents.
DK0466498T3 (en) Physiologically active peptides with immunoregulatory activities
ES2005143A6 (en) Tripeptide with immunostimulating activity
DE3476666D1 (en) Novel peptide, process for the preparation thereof and pharmaceutical composition containing said peptide
MY105110A (en) Low molecular weight derivatives of prourokinase and pharmaceutical compositions containing the same
GR3006212T3 (en)
AU7927987A (en) Pharmaceutical peptide compositions, also containing poly-d-3-hydroxybutyric acid and calcium acetate/glycerol adduct
ES8608861A1 (en) Hydrosoluble pharmaceutical compositions containing salts of (-)cis-1,2-epoxypropylphosphonic acid with aminoacids
JPS5372894A (en) Preparation of l-serine by fermentation
JPS53132539A (en) Protected amino acid or peptide having said protected amino acid residue
ATE69240T1 (en) MITOGENIC PEPTIDES.
JPS5287116A (en) Novel physiologically active peptide
ES8606248A1 (en) Process for the preparation of optically active glycine derivatives.
JPS5461170A (en) Preparation of coerulein and its analogs

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8701457-7

Format of ref document f/p: F